DMH-25

• Description:

  DMH25 is a novel covalent and potent inhibitor of mTOR and shows in vivo antitumor activity against triple-negative breast cancer cells.In vivo, DHM25 was an efficient inhibitor of growth and metastasis of triple-negative breast cancer cells, paving the way for its clinical application in oncology.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  489.94

• Molecular Formula:

  C15H8Br3NO3

• Notes:

  Research use only, not for human use.

• Receptor:

  MTOR

• CAS Number:

  1685280-21-0